Omeros reported $369.26M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 71.97M 5.92M
Adma Biologics ADMA:US $ 308.03M 31.78M
Aerie Pharmaceuticals AERI:US $ 395.55M 35.84M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Cytokinetics CYTK:US $ 856.25M 14.93M
Dynavax Technologies DVAX:US $ 1008.98M 30.27M
Gilead Sciences GILD:US $ 63080M 4872M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Insmed INSM:US $ 1.15B 90.19M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
Knight Therapeutics Inc GUD:CN C$ 995.42M 3.53M
Macrogenics MGNX:US $ 271.44M 63.8M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Omeros OMER:US $ 369.26M 50M
Pacira Pharmaceuticals PCRX:US $ 1891.48M 183.88M
Regulus Therapeutics RGLS:US $ 60.98M 7.47M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
United Therapeutics UTHR:US $ 5359.8M 190.7M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
Vital Therapies VTL:US $ 149.92M 10.82M
Xoma XOMA:US $ 159.16M 7.4M